Publicacións en colaboración con investigadores/as de University of Padua (79)

2023

  1. Photo-assembling cyclic peptides for dynamic light-driven peptide nanotubes

    Chem, Vol. 9, Núm. 11, pp. 3365-3378

2021

  1. Pyridazinones containing dithiocarbamoyl moieties as a new class of selective MAO-B inhibitors

    Bioorganic Chemistry, Vol. 115

  2. Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase

    European Journal of Medicinal Chemistry, Vol. 209

2020

  1. Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson's disease therapy

    Bioorganic Chemistry, Vol. 104

2017

  1. Multicomponent Assembly of the Kinesin Spindle Protein Inhibitor CPUYJ039 and Analogues as Antimitotic Agents

    ACS Combinatorial Science, Vol. 19, Núm. 3, pp. 153-160

2016

  1. Synthesis, biological evaluation and molecular modeling studies of phthalazin-1(2: H)-one derivatives as novel cholinesterase inhibitors

    RSC Advances, Vol. 6, Núm. 52, pp. 46170-46185

2014

  1. Structure-Based drug design and combinatorial chemistry in the search of antimitotic agents

    Current Topics in Medicinal Chemistry

2012

  1. A novel tetrahydrobenzoangelicin with dark and photo biological activity

    Bioorganic and Medicinal Chemistry, Vol. 20, Núm. 11, pp. 3603-3608

  2. Discovery of novel A 3 adenosine receptor ligands based on chromone scaffold

    Biochemical Pharmacology, Vol. 84, Núm. 1, pp. 21-29

  3. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2011

  1. Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors

    European Journal of Medicinal Chemistry, Vol. 46, Núm. 6, pp. 2185-2192

2010

  1. Pyridazinopsoralens of wide chemotherapeutic interest

    Bioorganic and Medicinal Chemistry, Vol. 18, Núm. 15, pp. 5708-5714

2009

  1. A new psoralen derivative with enlarged antiproliferative properties

    Bioorganic and Medicinal Chemistry Letters, Vol. 19, Núm. 10, pp. 2874-2876

2008

  1. Coumarin as attractive Casein Kinase 2 (CK2) inhibitor scaffold: An integrate approach to elucidate the putative binding motif and explain structure-activity relationships

    Journal of Medicinal Chemistry, Vol. 51, Núm. 4, pp. 752-759

2007

  1. On the applicability of QSAR for recognition of miRNA bioorganic structures at early stages of organism and cell development: Embryo and stem cells

    Bioorganic and Medicinal Chemistry, Vol. 15, Núm. 7, pp. 2544-2550

  2. Synthesis and structural characterisation of diorganotin(IV) and diphenyllead(IV) complexes of pyrimidine-2-thionate derivatives

    European Journal of Inorganic Chemistry, pp. 1444-1456

  3. Synthesis, structure and cytotoxicity of diorganotin(IV) complexes of 2,6-lutidine-α2,3-diol (Lu): The crystal structures of Lu and [SnMe2(H2O)(Lu-2H)]

    Journal of Organometallic Chemistry

  4. Tetramethylammonium bis(2-benzoyl-benzoato-κO)triphenylstannate(IV)

    Acta Crystallographica Section E: Structure Reports Online, Vol. 63, Núm. 2

2006

  1. A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins

    Journal of Medicinal Chemistry, Vol. 49, Núm. 3, pp. 1149-1156

  2. New furan side tetracyclic allopsoralen derivatives: Synthesis and photobiological evaluation

    Journal of Medicinal Chemistry, Vol. 49, Núm. 14, pp. 4317-4326